Global and United States Anti-Asthmatic Drugs Market Insights, Forecast to 2026

Global and United States Anti-Asthmatic Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Anti-Asthmatic Drugs Product Introduction
1.2 Market Segments
1.3 Key Anti-Asthmatic Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-Asthmatic Drugs Market Size Growth Rate by Type
1.4.2 Long-term Control Medications
1.4.3 Quick-relief Medications (Rescue Medications)
1.4.4 Medications for Allergy-induced Asthma
1.5 Market by Application
1.5.1 Global Anti-Asthmatic Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-Asthmatic Drugs Market Size, Estimates and Forecasts
2.1.1 Global Anti-Asthmatic Drugs Revenue 2015-2026
2.1.2 Global Anti-Asthmatic Drugs Sales 2015-2026
2.2 Global Anti-Asthmatic Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Anti-Asthmatic Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Anti-Asthmatic Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Anti-Asthmatic Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Anti-Asthmatic Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Anti-Asthmatic Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Anti-Asthmatic Drugs Revenue Forecast by Region (2021-2026)
3 Global Anti-Asthmatic Drugs Competitor Landscape by Players
3.1 Global Top Anti-Asthmatic Drugs Sales by Manufacturers
3.1.1 Global Anti-Asthmatic Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Anti-Asthmatic Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Anti-Asthmatic Drugs Manufacturers by Revenue
3.2.1 Global Anti-Asthmatic Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Anti-Asthmatic Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-Asthmatic Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-Asthmatic Drugs Revenue in 2019
3.2.5 Global Anti-Asthmatic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Anti-Asthmatic Drugs Price by Manufacturers
3.4 Global Anti-Asthmatic Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-Asthmatic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-Asthmatic Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anti-Asthmatic Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti-Asthmatic Drugs Market Size by Type (2015-2020)
4.1.1 Global Anti-Asthmatic Drugs Sales by Type (2015-2020)
4.1.2 Global Anti-Asthmatic Drugs Revenue by Type (2015-2020)
4.1.3 Anti-Asthmatic Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-Asthmatic Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-Asthmatic Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Asthmatic Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Anti-Asthmatic Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-Asthmatic Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti-Asthmatic Drugs Market Size by Application (2015-2020)
5.1.1 Global Anti-Asthmatic Drugs Sales by Application (2015-2020)
5.1.2 Global Anti-Asthmatic Drugs Revenue by Application (2015-2020)
5.1.3 Anti-Asthmatic Drugs Price by Application (2015-2020)
5.2 Anti-Asthmatic Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-Asthmatic Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Asthmatic Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Asthmatic Drugs Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Anti-Asthmatic Drugs Market Size YoY Growth 2015-2026
6.1.1 United States Anti-Asthmatic Drugs Sales YoY Growth 2015-2026
6.1.2 United States Anti-Asthmatic Drugs Revenue YoY Growth 2015-2026
6.1.3 United States Anti-Asthmatic Drugs Market Share in Global Market 2015-2026
6.2 United States Anti-Asthmatic Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Anti-Asthmatic Drugs Players by Sales (2015-2020)
6.2.2 United States Top Anti-Asthmatic Drugs Players by Revenue (2015-2020)
6.3 United States Anti-Asthmatic Drugs Historic Market Review by Type (2015-2020)
6.3.1 United States Anti-Asthmatic Drugs Sales Market Share by Type (2015-2020)
6.3.2 United States Anti-Asthmatic Drugs Revenue Market Share by Type (2015-2020)
6.3.3 United States Anti-Asthmatic Drugs Price by Type (2015-2020)
6.4 United States Anti-Asthmatic Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Anti-Asthmatic Drugs Sales Forecast by Type (2021-2026)
6.4.2 United States Anti-Asthmatic Drugs Revenue Forecast by Type (2021-2026)
6.4.3 United States Anti-Asthmatic Drugs Price Forecast by Type (2021-2026)
6.5 United States Anti-Asthmatic Drugs Historic Market Review by Application (2015-2020)
6.5.1 United States Anti-Asthmatic Drugs Sales Market Share by Application (2015-2020)
6.5.2 United States Anti-Asthmatic Drugs Revenue Market Share by Application (2015-2020)
6.5.3 United States Anti-Asthmatic Drugs Price by Application (2015-2020)
6.6 United States Anti-Asthmatic Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Anti-Asthmatic Drugs Sales Forecast by Application (2021-2026)
6.6.2 United States Anti-Asthmatic Drugs Revenue Forecast by Application (2021-2026)
6.6.3 United States Anti-Asthmatic Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Anti-Asthmatic Drugs Market Size YoY Growth 2015-2026
7.2 North America Anti-Asthmatic Drugs Market Facts & Figures by Country
7.2.1 North America Anti-Asthmatic Drugs Sales by Country (2015-2020)
7.2.2 North America Anti-Asthmatic Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Anti-Asthmatic Drugs Market Size YoY Growth 2015-2026
8.2 Europe Anti-Asthmatic Drugs Market Facts & Figures by Country
8.2.1 Europe Anti-Asthmatic Drugs Sales by Country
8.2.2 Europe Anti-Asthmatic Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Anti-Asthmatic Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Anti-Asthmatic Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Anti-Asthmatic Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Anti-Asthmatic Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Anti-Asthmatic Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Anti-Asthmatic Drugs Market Facts & Figures by Country
10.2.1 Latin America Anti-Asthmatic Drugs Sales by Country
10.2.2 Latin America Anti-Asthmatic Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Anti-Asthmatic Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Anti-Asthmatic Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Anti-Asthmatic Drugs Sales by Country
11.2.2 Middle East and Africa Anti-Asthmatic Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Abdi Ibrahim
12.1.1 Abdi Ibrahim Corporation Information
12.1.2 Abdi Ibrahim Description and Business Overview
12.1.3 Abdi Ibrahim Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Abdi Ibrahim Anti-Asthmatic Drugs Products Offered
12.1.5 Abdi Ibrahim Recent Development
12.2 Ception Therapeutics
12.2.1 Ception Therapeutics Corporation Information
12.2.2 Ception Therapeutics Description and Business Overview
12.2.3 Ception Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Ception Therapeutics Anti-Asthmatic Drugs Products Offered
12.2.5 Ception Therapeutics Recent Development
12.3 Elan
12.3.1 Elan Corporation Information
12.3.2 Elan Description and Business Overview
12.3.3 Elan Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Elan Anti-Asthmatic Drugs Products Offered
12.3.5 Elan Recent Development
12.4 Innoviva
12.4.1 Innoviva Corporation Information
12.4.2 Innoviva Description and Business Overview
12.4.3 Innoviva Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Innoviva Anti-Asthmatic Drugs Products Offered
12.4.5 Innoviva Recent Development
12.5 Novartis
12.5.1 Novartis Corporation Information
12.5.2 Novartis Description and Business Overview
12.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis Anti-Asthmatic Drugs Products Offered
12.5.5 Novartis Recent Development
12.6 Sanofi
12.6.1 Sanofi Corporation Information
12.6.2 Sanofi Description and Business Overview
12.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sanofi Anti-Asthmatic Drugs Products Offered
12.6.5 Sanofi Recent Development
12.7 Mitsubishi Tanabe Pharma
12.7.1 Mitsubishi Tanabe Pharma Corporation Information
12.7.2 Mitsubishi Tanabe Pharma Description and Business Overview
12.7.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Products Offered
12.7.5 Mitsubishi Tanabe Pharma Recent Development
12.8 Menarini
12.8.1 Menarini Corporation Information
12.8.2 Menarini Description and Business Overview
12.8.3 Menarini Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Menarini Anti-Asthmatic Drugs Products Offered
12.8.5 Menarini Recent Development
12.9 Dong-A Socio Holdings
12.9.1 Dong-A Socio Holdings Corporation Information
12.9.2 Dong-A Socio Holdings Description and Business Overview
12.9.3 Dong-A Socio Holdings Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Dong-A Socio Holdings Anti-Asthmatic Drugs Products Offered
12.9.5 Dong-A Socio Holdings Recent Development
12.10 Lonza
12.10.1 Lonza Corporation Information
12.10.2 Lonza Description and Business Overview
12.10.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Lonza Anti-Asthmatic Drugs Products Offered
12.10.5 Lonza Recent Development
12.11 Abdi Ibrahim
12.11.1 Abdi Ibrahim Corporation Information
12.11.2 Abdi Ibrahim Description and Business Overview
12.11.3 Abdi Ibrahim Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Abdi Ibrahim Anti-Asthmatic Drugs Products Offered
12.11.5 Abdi Ibrahim Recent Development
12.12 Regeneron Pharmaceuticals
12.12.1 Regeneron Pharmaceuticals Corporation Information
12.12.2 Regeneron Pharmaceuticals Description and Business Overview
12.12.3 Regeneron Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Regeneron Pharmaceuticals Products Offered
12.12.5 Regeneron Pharmaceuticals Recent Development
12.13 Theravance Biopharma
12.13.1 Theravance Biopharma Corporation Information
12.13.2 Theravance Biopharma Description and Business Overview
12.13.3 Theravance Biopharma Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Theravance Biopharma Products Offered
12.13.5 Theravance Biopharma Recent Development
12.14 Lonza
12.14.1 Lonza Corporation Information
12.14.2 Lonza Description and Business Overview
12.14.3 Lonza Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Lonza Products Offered
12.14.5 Lonza Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Anti-Asthmatic Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-Asthmatic Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Anti-Asthmatic Drugs Market Segments
Table 2. Ranking of Global Top Anti-Asthmatic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-Asthmatic Drugs Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Long-term Control Medications
Table 5. Major Manufacturers of Quick-relief Medications (Rescue Medications)
Table 6. Major Manufacturers of Medications for Allergy-induced Asthma
Table 7. Global Anti-Asthmatic Drugs Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 8. Global Anti-Asthmatic Drugs Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 9. Global Anti-Asthmatic Drugs Sales by Regions 2015-2020 (K Doses)
Table 10. Global Anti-Asthmatic Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Anti-Asthmatic Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Anti-Asthmatic Drugs Sales Forecast by Region (2021-2026) (K Doses)
Table 13. Global Anti-Asthmatic Drugs Sales by Manufacturers (2015-2020) (K Doses)
Table 14. Global Anti-Asthmatic Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Anti-Asthmatic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Anti-Asthmatic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Asthmatic Drugs as of 2019)
Table 17. Anti-Asthmatic Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Anti-Asthmatic Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Anti-Asthmatic Drugs Price (2015-2020) (USD/Dose)
Table 20. Anti-Asthmatic Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Anti-Asthmatic Drugs Product Type
Table 22. Date of International Manufacturers Enter into Anti-Asthmatic Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-Asthmatic Drugs Sales by Type (2015-2020) (K Doses)
Table 25. Global Anti-Asthmatic Drugs Sales Share by Type (2015-2020)
Table 26. Global Anti-Asthmatic Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Anti-Asthmatic Drugs Revenue Share by Type (2015-2020)
Table 28. Anti-Asthmatic Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 29. Global Anti-Asthmatic Drugs Sales Share by Type (2021-2026)
Table 30. Global Anti-Asthmatic Drugs Sales by Application (2015-2020) (K Doses)
Table 31. Global Anti-Asthmatic Drugs Sales Share by Application (2015-2020)
Table 32. Global Anti-Asthmatic Drugs Sales Share by Application (2021-2026)
Table 33. Global Anti-Asthmatic Drugs Sales Market Share Forecast by Application (2021-2026)
Table 34. Global Anti-Asthmatic Drugs Revenue by Application (2015-2020) (US$ Million)
Table 35. Global Anti-Asthmatic Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 36. United States Anti-Asthmatic Drugs Sales (K Doses) of Key Companies (2015-2020)
Table 37. United States Anti-Asthmatic Drugs Sales Share by Company (2015-2020)
Table 38. United States Anti-Asthmatic Drugs Revenue (US$ Million) by Company (2015-2020)
Table 39. United States Anti-Asthmatic Drugs Sales (K Doses) by Type (2015-2020)
Table 40. United States Anti-Asthmatic Drugs Sales Share by Type (2015-2020)
Table 41. United States Anti-Asthmatic Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. United States Anti-Asthmatic Drugs Price (K Doses) by Type (2015-2020)
Table 43. United States Anti-Asthmatic Drugs Sales (K Doses) by Type (2021-2026)
Table 44. United States Anti-Asthmatic Drugs Sales Share by Type (2021-2026)
Table 45. United States Anti-Asthmatic Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. United States Anti-Asthmatic Drugs Revenue Share by Type (2021-2026)
Table 47. United States Anti-Asthmatic Drugs Price (K Doses) by Type (2021-2026)
Table 48. United States Anti-Asthmatic Drugs Sales (K Doses) by Application (2015-2020)
Table 49. United States Anti-Asthmatic Drugs Sales Share by Application (2015-2020)
Table 50. United States Anti-Asthmatic Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. United States Anti-Asthmatic Drugs Sales (K Doses) by Application (2021-2026)
Table 52. United States Anti-Asthmatic Drugs Sales Share by Application (2021-2026)
Table 53. United States Anti-Asthmatic Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. United States Anti-Asthmatic Drugs Revenue Share by Application (2021-2026)
Table 55. North America Anti-Asthmatic Drugs Sales by Country (2015-2020) (K Doses)
Table 56. North America Anti-Asthmatic Drugs Sales Market Share by Country (2015-2020)
Table 57. North America Anti-Asthmatic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. North America Anti-Asthmatic Drugs Revenue Market Share by Country (2015-2020)
Table 59. Europe Anti-Asthmatic Drugs Sales by Country (2015-2020) (K Doses)
Table 60. Europe Anti-Asthmatic Drugs Sales Market Share by Country (2015-2020)
Table 61. Europe Anti-Asthmatic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe Anti-Asthmatic Drugs Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific Anti-Asthmatic Drugs Sales by Region (2015-2020) (K Doses)
Table 64. Asia Pacific Anti-Asthmatic Drugs Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific Anti-Asthmatic Drugs Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific Anti-Asthmatic Drugs Revenue Market Share by Region (2015-2020)
Table 67. Latin America Anti-Asthmatic Drugs Sales by Country (2015-2020) (K Doses)
Table 68. Latin America Anti-Asthmatic Drugs Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa Anti-Asthmatic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America Anti-Asthmatic Drugs Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Anti-Asthmatic Drugs Sales by Country (2015-2020) (K Doses)
Table 72. Middle East and Africa Anti-Asthmatic Drugs Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa Anti-Asthmatic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa Anti-Asthmatic Drugs Revenue Market Share by Country (2015-2020)
Table 75. Abdi Ibrahim Corporation Information
Table 76. Abdi Ibrahim Description and Business Overview
Table 77. Abdi Ibrahim Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Abdi Ibrahim Anti-Asthmatic Drugs Product
Table 79. Abdi Ibrahim Recent Development
Table 80. Ception Therapeutics Corporation Information
Table 81. Ception Therapeutics Description and Business Overview
Table 82. Ception Therapeutics Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Ception Therapeutics Product
Table 84. Ception Therapeutics Recent Development
Table 85. Elan Corporation Information
Table 86. Elan Description and Business Overview
Table 87. Elan Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Elan Product
Table 89. Elan Recent Development
Table 90. Innoviva Corporation Information
Table 91. Innoviva Description and Business Overview
Table 92. Innoviva Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Innoviva Product
Table 94. Innoviva Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Novartis Product
Table 99. Novartis Recent Development
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Sanofi Product
Table 104. Sanofi Recent Development
Table 105. Mitsubishi Tanabe Pharma Corporation Information
Table 106. Mitsubishi Tanabe Pharma Description and Business Overview
Table 107. Mitsubishi Tanabe Pharma Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Mitsubishi Tanabe Pharma Product
Table 109. Mitsubishi Tanabe Pharma Recent Development
Table 110. Menarini Corporation Information
Table 111. Menarini Description and Business Overview
Table 112. Menarini Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Menarini Product
Table 114. Menarini Recent Development
Table 115. Dong-A Socio Holdings Corporation Information
Table 116. Dong-A Socio Holdings Description and Business Overview
Table 117. Dong-A Socio Holdings Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 118. Dong-A Socio Holdings Product
Table 119. Dong-A Socio Holdings Recent Development
Table 120. Lonza Corporation Information
Table 121. Lonza Description and Business Overview
Table 122. Lonza Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Lonza Product
Table 124. Lonza Recent Development
Table 125. Sosei Corporation Information
Table 126. Sosei Description and Business Overview
Table 127. Sosei Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Sosei Product
Table 129. Sosei Recent Development
Table 130. Regeneron Pharmaceuticals Corporation Information
Table 131. Regeneron Pharmaceuticals Description and Business Overview
Table 132. Regeneron Pharmaceuticals Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. Regeneron Pharmaceuticals Product
Table 134. Regeneron Pharmaceuticals Recent Development
Table 135. Theravance Biopharma Corporation Information
Table 136. Theravance Biopharma Description and Business Overview
Table 137. Theravance Biopharma Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 138. Theravance Biopharma Product
Table 139. Theravance Biopharma Recent Development
Table 140. Lonza Corporation Information
Table 141. Lonza Description and Business Overview
Table 142. Lonza Anti-Asthmatic Drugs Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 143. Lonza Product
Table 144. Lonza Recent Development
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Anti-Asthmatic Drugs Players
Table 149. Anti-Asthmatic Drugs Customers List
Table 150. Anti-Asthmatic Drugs Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Asthmatic Drugs Product Picture
Figure 2. Global Anti-Asthmatic Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Long-term Control Medications Product Picture
Figure 4. Quick-relief Medications (Rescue Medications) Product Picture
Figure 5. Medications for Allergy-induced Asthma Product Picture
Figure 6. Global Anti-Asthmatic Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacy
Figure 8. Retail Pharmacy
Figure 9. Online Pharmacy
Figure 10. Anti-Asthmatic Drugs Report Years Considered
Figure 11. Global Anti-Asthmatic Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Anti-Asthmatic Drugs Sales 2015-2026 (K Doses)
Figure 13. Global Anti-Asthmatic Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Anti-Asthmatic Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Anti-Asthmatic Drugs Sales Market Share by Region in 2019
Figure 16. Global Anti-Asthmatic Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Anti-Asthmatic Drugs Revenue Market Share by Region in 2019
Figure 18. Global Anti-Asthmatic Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Anti-Asthmatic Drugs Revenue in 2019
Figure 20. Anti-Asthmatic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Anti-Asthmatic Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Anti-Asthmatic Drugs Sales Market Share by Type in 2019
Figure 23. Global Anti-Asthmatic Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Anti-Asthmatic Drugs Revenue Market Share by Type in 2019
Figure 25. Global Anti-Asthmatic Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Anti-Asthmatic Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Anti-Asthmatic Drugs Sales Market Share by Application in 2019
Figure 28. Global Anti-Asthmatic Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Anti-Asthmatic Drugs Revenue Market Share by Application in 2019
Figure 30. United States Anti-Asthmatic Drugs Sales Growth Rate 2015-2026 (K Doses)
Figure 31. United States Anti-Asthmatic Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 32. United States Anti-Asthmatic Drugs Market Share in Global Market 2015-2026
Figure 33. United States 5 and 10 Largest Anti-Asthmatic Drugs Players Market Share by Revenue in Anti-Asthmatic Drugs in 2019
Figure 34. United States Anti-Asthmatic Drugs Revenue Share by Type (2015-2020)
Figure 35. United States Anti-Asthmatic Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 36. United States Anti-Asthmatic Drugs Revenue Share by Application (2015-2020)
Figure 37. United States Anti-Asthmatic Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 38. North America Anti-Asthmatic Drugs Sales Growth Rate 2015-2020 (K Doses)
Figure 39. North America Anti-Asthmatic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Anti-Asthmatic Drugs Sales Market Share by Country in 2019
Figure 41. North America Anti-Asthmatic Drugs Revenue Market Share by Country in 2019
Figure 42. U.S. Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 43. U.S. Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Canada Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Europe Anti-Asthmatic Drugs Sales Growth Rate 2015-2020 (K Doses)
Figure 47. Europe Anti-Asthmatic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Anti-Asthmatic Drugs Sales Market Share by Country in 2019
Figure 49. Europe Anti-Asthmatic Drugs Revenue Market Share by Country in 2019
Figure 50. Germany Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Germany Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 53. France Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 55. U.K. Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 57. Italy Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 59. Russia Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Asia Pacific Anti-Asthmatic Drugs Sales Growth Rate 2015-2020 (K Doses)
Figure 61. Asia Pacific Anti-Asthmatic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Anti-Asthmatic Drugs Sales Market Share by Region in 2019
Figure 63. Asia Pacific Anti-Asthmatic Drugs Revenue Market Share by Region in 2019
Figure 64. China Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 65. China Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Japan Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 69. South Korea Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 71. India Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Australia Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Taiwan Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Indonesia Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Thailand Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Malaysia Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 83. Philippines Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 85. Vietnam Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Latin America Anti-Asthmatic Drugs Sales Growth Rate 2015-2020 (K Doses)
Figure 87. Latin America Anti-Asthmatic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Anti-Asthmatic Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Anti-Asthmatic Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Mexico Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Brazil Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Anti-Asthmatic Drugs Sales Growth Rate (2015-2020) (K Doses)
Figure 95. Argentina Anti-Asthmatic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Middle East and Africa Anti-Asthmatic Drugs Sales Growth Rate 2015-2020 (K Doses)
Figure 97. Middle East and Africa Anti-Asthmatic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Anti-Asthmatic Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Anti-Asthmatic Drugs Revenue Market Share by Country in 2019

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs